-+ 0.00%
-+ 0.00%
-+ 0.00%
Placo announced that the “denavirin hydrochloride injection” jointly declared by the company's wholly-owned subsidiary Luoyang Huizhong Veterinary Medicine Co., Ltd. and other organizations was approved as a Class II new veterinary drug after review by the Ministry of Agriculture and Rural Affairs. The Ministry of Agriculture and Rural Affairs announced and issued the “New Veterinary Drug Registration Certificate” on September 14, 2026. This product still needs to obtain a veterinary drug product approval number before it is marketed.
Share
Listen to the news
Placo announced that the “denavirin hydrochloride injection” jointly declared by the company's wholly-owned subsidiary Luoyang Huizhong Veterinary Medicine Co., Ltd. and other organizations was approved as a Class II new veterinary drug after review by the Ministry of Agriculture and Rural Affairs. The Ministry of Agriculture and Rural Affairs announced and issued the “New Veterinary Drug Registration Certificate” on September 14, 2026. This product still needs to obtain a veterinary drug product approval number before it is marketed.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending